We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Trauma Centers Boost Head Injury Survival

By HospiMedica staff writers
Posted on 28 Apr 2005
Head-injury patients who are transferred to level I trauma centers are more likely to survive than those transferred to level II facilities, according to a new study published in the journal Health Services Research.

Researchers analyzed data on 542 patients sent from 31 rural trauma centers to level I and II trauma centers between 1991 and 1994. More...
The study population included patients with simple concussions as well as patients with fatal traumatic brain injury. Mortality was based on death during hospitalization or within 30 days of discharge.

The research team found that mortality dropped 10% among patients transferred to level II centers. Level I centers provide comprehensive trauma care, including trauma doctors in every specialty who are immediately available, and must have resuscitation, neuroradiology, and hemodialysis technology. Also, they have training programs and are required to treat 1,200 injured patients or 240 major trauma patients annually. Level II centers have less-stringent volume performance standards and are not required to have teaching and research programs.

"Our results suggest that some of the operational and philosophical differences in the acute management of head-injured persons between level I and level II centers may actually translate into improved survival among patients initially presenting to rural hospitals and transferred to level I centers versus those transferred to level II centers,” noted co-author Craig Newgard, M.D., assistant professor of emergency medicine, Oregon Health & Science University (Portland, USA).






Related Links:
Oregon Health & Science U

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.